Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeys.
Saved in:
| Title: | Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeys. |
|---|---|
| Authors: | Ruthsatz, Tanja1 (AUTHOR), Wymann, Sandra2 (AUTHOR), Velkoska, Elena3 (AUTHOR), Mansour, Mariam3 (AUTHOR), Schu, Daniel4 (AUTHOR), Lichtfuss, Marit3 (AUTHOR), Rossato, Paolo4 (AUTHOR), FitzPatrick, Meaghan3 (AUTHOR), Hosback, Sarah3 (AUTHOR), Dyson, Allison3 (AUTHOR), Herzog, Eva5 (AUTHOR), Martin, Kirstee3 (AUTHOR), Dietrich, Barbara1 (AUTHOR), Hardy, Matthew P.1,3 (AUTHOR) matt.hardy@csl.com.au |
| Source: | Toxicology & Applied Pharmacology. Feb2025, Vol. 495, pN.PAG-N.PAG. 1p. |
| Database: | Environment Complete |
| ISSN: | 0041008X |
|---|---|
| DOI: | 10.1016/j.taap.2024.117191 |
